Efficacy and safety of niraparib in patients aged 65 years and older with advanced ovarian cancer: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial.
Valabrega G, Pothuri B, Oaknin A, Graybill WS, Sánchez AB, McCormick C, Baurain JF, Tinker AV, Denys H, O'Cearbhaill RE, Hietanen S, Moore RG, Knudsen AØ, de La Motte Rouge T, Heitz F, Levy T, York W, Gupta D, Monk BJ, González-Martín A.
Valabrega G, et al. Among authors: gupta d.
Gynecol Oncol. 2024 Jun 3;187:128-138. doi: 10.1016/j.ygyno.2024.03.009. Online ahead of print.
Gynecol Oncol. 2024.
PMID: 38833992